Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
BMC Family Practice|May 13, 2010
Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial. Design of a randomised controlled patient-preference equivalence trial in primary carePaulien R Wermeling, Maureen van den Donk, Kees J Gorter, et al.Nederlands Tijdschrift Voor Geneeskunde|May 12, 2010
[Detection of metabolic syndrome by self-measurement of waist circumference]Corine den Engelsen, Maureen van den Donk, Kees J Gorter, et al.Journal of the Neurological Sciences|November 19, 2011
Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes--the ADDITION-Netherlands study: a cluster-randomized trialPaula S Koekkoek, Carla Ruis, Maureen van den Donk, et al.The Cochrane Database of Systematic Reviews|September 19, 2016
Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic controlRimke C Vos, Mariëlle Jp van Avendonk, Hanneke Jansen, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control studyMaureen van den Donk, Brian Buijsse, Saskia W van den Berg, et al.Diabetes Care|November 26, 2009
Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular riskFrits G W Cleveringa, Paco M J Welsing, Maureen van den Donk, et al.Diabetologia|August 21, 2013
Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trialMaureen Van den Donk, Simon J Griffin, Rebecca K Stellato, et al.Lancet (London, England)|June 28, 2011
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trialSimon J Griffin, Knut Borch-Johnsen, Melanie J Davies, et al.Diabetes Care|May 3, 2014
Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe StudyAnnelli Sandbæk, Simon J Griffin, Stephen J Sharp, et al.The Journal of Nutrition|August 22, 2007
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomasMaureen van den Donk, Linette Pellis, Jimmy W Crott, et al.Pageof 4